Literature DB >> 20170369

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.

Ally Ibrahim Olotu, Gregory Fegan, Philip Bejon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20170369     DOI： 10.1086/651025

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

1.  A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.

Authors:  Takayuki Shiratsuchi; Urvashi Rai; Izumi Kaneko; Min Zhang; Shiroh Iwanaga; Masao Yuda; Moriya Tsuji
Journal:  Vaccine       Date:  2017-10-28       Impact factor: 3.641

Review 2.  Advances and challenges in malaria vaccine development.

Authors:  Peter D Crompton; Susan K Pierce; Louis H Miller
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

3.  Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.

Authors:  Michael T White; Jamie T Griffin; Eleanor M Riley; Chris J Drakeley; Ann M Moorman; Peter Odada Sumba; James W Kazura; Azra C Ghani; Chandy C John
Journal:  Proc Biol Sci       Date:  2010-10-13       Impact factor: 5.349

4.  Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.

Authors:  Ally Olotu; Philippe Moris; Jedidah Mwacharo; Johan Vekemans; Domtila Kimani; Michel Janssens; Oscar Kai; Erik Jongert; Marc Lievens; Amanda Leach; Tonya Villafana; Barbara Savarese; Kevin Marsh; Joe Cohen; Philip Bejon
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

Review 5.  Vaccines against malaria.

Authors:  Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

6.  Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.

Authors:  Ally Olotu; Frederic Clement; Erik Jongert; Johan Vekemans; Patricia Njuguna; Francis M Ndungu; Kevin Marsh; Geert Leroux-Roels; Philip Bejon
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

7.  Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.

Authors:  Christian F Ockenhouse; Jason Regules; Donna Tosh; Jessica Cowden; April Kathcart; James Cummings; Kristopher Paolino; James Moon; Jack Komisar; Edwin Kamau; Thomas Oliver; Austin Chhoeu; Jitta Murphy; Kirsten Lyke; Matthew Laurens; Ashley Birkett; Cynthia Lee; Rich Weltzin; Ulrike Wille-Reece; Martha Sedegah; Jenny Hendriks; Isabella Versteege; Maria Grazia Pau; Jerold Sadoff; Yannick Vanloubbeeck; Marc Lievens; Dirk Heerwegh; Philippe Moris; Yolanda Guerra Mendoza; Erik Jongert; Joe Cohen; Gerald Voss; W Ripley Ballou; Johan Vekemans
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.

Authors:  Michael T White; Philip Bejon; Ally Olotu; Jamie T Griffin; Eleanor M Riley; Kent E Kester; Christian F Ockenhouse; Azra C Ghani
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.

Authors:  Frederic Clement; Vincent Dewar; Eva Van Braeckel; Isabelle Desombere; Marianne Dewerchin; Christine Swysen; Marie-Ange Demoitié; Erik Jongert; Joe Cohen; Geert Leroux-Roels; Pierre Cambron
Journal:  Malar J       Date:  2012-11-22       Impact factor: 2.979

10.  Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.

Authors:  Craig Przysiecki; Bob Lucas; Robert Mitchell; Daniel Carapau; Zhiyun Wen; Hui Xu; Xin-Min Wang; Debbie Nahas; Chengwei Wu; Robert Hepler; Elizabeth Ottinger; Jan Ter Meulen; David Kaslow; John Shiver; Elizabeth Nardin
Journal:  Front Cell Infect Microbiol       Date:  2012-11-30       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.